Located in Busan company SNVIA Co., Ltd. is accelerating commercialization and product development efforts by partnering with a Japanese firm to leverage photo-crosslinking technology.SNVIA, a company specializing in the development of photocrosslinking-based medical devices, signed a memorandum of understanding (MOU) on the 24th with Japan Bio Products Co., Ltd. (JBP), headquartered in Shibuya, Tokyo. The agreement aims at the joint development and commercialization of medical devices for disease treatment and aesthetic applications using photocrosslinking polymer technology. Through the agreement, the two companies also reached a consensus on key joint development milestones toward bringing the products to market.